Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathwayJournal of Experimental & Clinical Cancer ResearchJune 18, 201910.1186/s13046-019-1251-7Cited by 150SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis